James M. Backes

Effectiveness and Tolerability of Every-Other-Day Rosuvastatin Dosing in Patients with Prior Statin Intolerance

James M. Backes, Cheryl Gibson, Janelle F. Ruisinger et al. · Annals of Pharmacotherapy · 2008 · 129 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Quality of diabetes care for adults with developmental disabilities

Theresa I. Shireman, Amanda Reichard, Niaman Nazir et al. · Disability and health journal · 2009 · 74 citations

Medicine, Internal Medicine, Diabetology +9

Once-a-Week Rosuvastatin (2.5 to 20 mg) in Patients With a Previous Statin Intolerance

Janelle F. Ruisinger, James M. Backes, Cheryl Gibson et al. · The American Journal of Cardiology · 2008 · 68 citations

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +4

Effects of Once Weekly Rosuvastatin Among Patients With a Prior Statin Intolerance††Conflicts of interest: Dr. Backes is with the Speakers Bureau of Abbott Labs, Abbott Park, Illinois. Dr. Moriarty receives research funding from and is a consultant for B Braun. Dr. Moriarty has also been a consultant for sanofi aventis, Bridgewater, New Jersey, and Reliant Pharmaceuticals, Liberty Corner, New Jersey; with the Speakers Bureaus of Astra Zeneca, Wilmington, Delaware; Abbott Labs, Abbott Park, Illinois; Merck/Schering-Plough, Whitehouse Station, New Jersey, and Takeda Pharmaceuticals, Deerfield, Illinois; and has performed contracted research for Kos Pharmaceuticals, Abbott Park, Illinois; sanofi aventis; Novartis, Basel, Switzerland, HELP Inc., Dover, Delaware; and Kaneka, NY, NY.

James M. Backes, Patrick M. Moriarty, Janelle F. Ruisinger et al. · The American Journal of Cardiology · 2007 · 58 citations

Medicine, Pharmacology, Pharmacotherapy +10

Statins and almonds to lower lipoproteins (the STALL Study)

Janelle F. Ruisinger, Cheryl Gibson, James M. Backes et al. · Journal of clinical lipidology · 2014 · 44 citations

Life Sciences, Nutrition, Nutritional Sciences +11